September 6, 2024 — Think about it. Profound change is coming to healthcare and health systems because of the imperative for obesity care at scale. Right now, we are seeing only a faint glimmer of the changes that lie ahead. That’s because the biggest struggles with this change are very basic. Lilly and Novo Nordisk are straining to produce […]
July 19, 2024 — “If we were just to get a fraction [of potential members] to engage in the way that we do things differently with GLP-1s – it’s an insane opportunity for the company.” These words come from the Life Time chain of fitness clubs about the “Miora” wellness clinics they are now putting inside their facilities. It […]
September 12, 2023 — People are beginning to discover a major side effect of advanced meds for obesity that is not gastrointestinal – it’s economic disruption. Retailers, food makers, and participants in the huge business of health systems are all just starting to wrap their heads around the disruptive potential of more accessible and effective obesity treatment. Already, the […]
